Drug regulation has failed to keep up with a globalized world and governments should harmonize oversight to improve patients' access to new and innovative medicines.
That is the view of the former leader of the U.S. Food and Drug Administration (FDA), the world's top drug regulator, and the research head of French drugmaker Sanofi, who made a joint plea to governments for action on Wednesday.
Read Full Article »